Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
54
ACLX Quote, Financials, Valuation and Earnings
Last price:
$113.82
Seasonality move
:
-5.46%
Day range:
$113.70 - $114.26
52-week range:
$47.86 - $114.26
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
176.15x
P/B ratio:
14.92x
Volume:
32.9M
Avg. volume:
1.9M
1-year change:
78.43%
Market cap:
$6.6B
Revenue:
$107.9M
EPS (TTM):
-$3.92
Analysts' Opinion
-
Consensus RatingArcellx, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 7 Buy ratings, 11 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $110.43, Arcellx, Inc. has an estimated downside of -2.92% from its current price of $113.75.
-
Price Target UpsideAccording to analysts, the highest upside price target is $127.00 representing 11.65% upside increase from its current price of $113.75.
Fair Value
-
According to the consensus of 18 analysts, Arcellx, Inc. has -2.92% downside to fair value with a price target of $110.43 per share.
ACLX vs. S&P 500
-
Over the past 5 trading days, Arcellx, Inc. has overperformed the S&P 500 by 67.12% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Arcellx, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Arcellx, Inc. revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Arcellx, Inc. reported revenues of $4.9M.
Earnings Growth
-
Arcellx, Inc. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Arcellx, Inc. reported earnings per share of -$0.99.
Enterprise value:
6.2B
EV / Invested capital:
--
Price / LTM sales:
176.15x
EV / EBIT:
--
EV / Revenue:
171.81x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
-30.66x
Price / Operating cash flow:
895.28x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$29.1M
Return On Assets:
-32.05%
Net Income Margin (TTM):
-607.01%
Return On Equity:
-49.8%
Return On Invested Capital:
-44.21%
Operating Margin:
-1248.25%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $47.2M | $155.8M | $35.9M | $26M | $4.9M | |
| Gross Profit | $44.6M | $151.7M | $29.1M | $24.7M | $3.1M | |
| Operating Income | -$144.9M | -$69.4M | -$242.6M | -$33.6M | -$61.8M | |
| EBITDA | -$142.3M | -$65.3M | -$235.7M | -$32.3M | -$59.9M | |
| Diluted EPS | -$2.78 | -$0.75 | -$3.92 | -$0.48 | -$0.99 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $290.3M | $491.5M | $587.3M | $472.1M | |
| Total Assets | -- | $337.3M | $614.2M | $764.9M | $655.9M | |
| Current Liabilities | -- | $44.8M | $173.1M | $137M | $118.4M | |
| Total Liabilities | -- | $101M | $348.1M | $281.9M | $215.1M | |
| Total Equity | -- | $236.3M | $266.1M | $483M | $440.8M | |
| Total Debt | -- | $84M | $102.1M | $58.1M | $44.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $121.8M | $20.8M | -$198.1M | $30.7M | -$49.2M | |
| Cash From Investing | -$141.9M | -$157.9M | $24.4M | $35.8M | -$20M | |
| Cash From Financing | $91.9M | $170.5M | $90.9M | -$4.7M | $86.1M | |
| Free Cash Flow | $104.4M | $3.6M | -$201.2M | $28.4M | -$49.5M | |
ACLX
Sector
Market Cap
$6.6B
$25.4M
Price % of 52-Week High
99.55%
49.16%
Dividend Yield
0%
0%
Shareholder Yield
-2.86%
-1.79%
1-Year Price Total Return
78.43%
-22.36%
Beta (5-Year)
--
0.499
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$73.83
200-day SMA
Buy
Level
$72.23
Bollinger Bands (100)
Buy
Level
65.59 - 86.37
Chaikin Money Flow
Sell
Level
-12.8M
20-day SMA
Buy
Level
$70.59
Relative Strength Index (RSI14)
Buy
Level
83.72
ADX Line
Buy
Level
20.63
Williams %R
Sell
Level
-0.9978
50-day SMA
Buy
Level
$68.22
MACD (12, 26)
Buy
Level
3.36
25-day Aroon Oscillator
Buy
Level
4
On Balance Volume
Neutral
Level
34.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.0737)
Sell
CA Score
(Annual)
Level (-0.7041)
Buy
Beneish M-Score
(Annual)
Level (-4.0985)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.1087)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Redwood City MD.
Stock Forecast FAQ
In the current month, ACLX has received 7 Buy ratings 11 Hold ratings, and 0 Sell ratings. The ACLX average analyst price target in the past 3 months is $110.43.
-
Where Will Arcellx, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Arcellx, Inc. share price will drop to $110.43 per share over the next 12 months.
-
What Do Analysts Say About Arcellx, Inc.?
Analysts are divided on their view about Arcellx, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Arcellx, Inc. is a Sell and believe this share price will rise from its current level to $82.00.
-
What Is Arcellx, Inc.'s Price Target?
The price target for Arcellx, Inc. over the next 1-year time period is forecast to be $110.43 according to 18 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 11 analysts rate the stock a Hold.
-
Is ACLX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Arcellx, Inc. is a Hold. 11 of 18 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ACLX?
You can purchase shares of Arcellx, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Arcellx, Inc. shares.
-
What Is The Arcellx, Inc. Share Price Today?
Arcellx, Inc. was last trading at $113.82 per share. This represents the most recent stock quote for Arcellx, Inc.. Yesterday, Arcellx, Inc. closed at $113.75 per share.
-
How To Buy Arcellx, Inc. Stock Online?
In order to purchase Arcellx, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ACLX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ACLX
Sector
P/E ratio
--
23.36x
PEG ratio
-0.07x
-0.01x
P/B ratio
14.92x
1.77x
Price / LTM sales
176.15x
1.56x
Growth Metrics
ACLX
Sector
Revenue growth
-80.99%
3.51%
Earnings growth
-105.12%
9.66%
Revenue (5-year growth)
--
6.44%
Earnings forecast
-$1.05
-$0.19
Profitability
ACLX
Sector
Profitability FY 2024
$102.7M
$2.6M
Return on invested capital
-44.21%
-33.43%
Return on assets
-32.05%
-29.68%
Return on equity
-49.8%
-38.71%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
4
Balance Sheet
ACLX
Sector
Total cash
$461.4M
$25M
Short term investments
$481.7M
$24M
Total assets
$711.3M
$71.6M
Long term debt
$44.3M
$2.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.7T
P/E Ratio: 65x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 36x
Sell
48
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
54
ACLX alert for Feb 24
Arcellx, Inc. [ACLX] is up 0.08% over the past day.
Buy
73
HYMC alert for Feb 24
Hycroft Mining Holding Corp. [HYMC] is up 3% over the past day.
Sell
39
SCL alert for Feb 24
Stepan Co. [SCL] is down 0.41% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
